miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
出版年份 2015 全文链接
标题
miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
作者
关键词
-
出版物
Pigment Cell & Melanoma Research
Volume 28, Issue 4, Pages 431-441
出版商
Wiley
发表日期
2015-04-22
DOI
10.1111/pcmr.12379
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog
- (2014) Anurag N Paranjape et al. BMC CANCER
- The role of microRNAs in melanoma
- (2014) Chonglin Luo et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication
- (2014) Andrea Piunti et al. Nature Communications
- Resistance to BRAF-targeted therapy in melanoma
- (2013) Ryan J. Sullivan et al. EUROPEAN JOURNAL OF CANCER
- miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1
- (2012) Shujing Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Chromatin-modifying enzymes as modulators of reprogramming
- (2012) Tamer T. Onder et al. NATURE
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
- (2012) Florian Kopp et al. PLoS One
- Snail1 Mediates Hypoxia-Induced Melanoma Progression
- (2011) Shujing Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma
- (2011) Gerhard F. Huber et al. CANCER
- PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
- (2011) K. H. T. Paraiso et al. CANCER RESEARCH
- Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
- (2011) Zhe-Sheng Chen et al. FEBS Journal
- Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer
- (2011) Bao-Hong Guo et al. Molecular Cancer
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice
- (2011) A. T. Franco et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- MEK-Independent Survival of B-RAFV600E Melanoma Cells Selected for Resistance to Apoptosis Induced by the RAF Inhibitor PLX4720
- (2010) C. C. Jiang et al. CLINICAL CANCER RESEARCH
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
- (2010) Zhiwei Wang et al. DRUG RESISTANCE UPDATES
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
- (2009) Yohei Shimono et al. CELL
- Mechanism of Drug Sensitivity and Resistance in Melanoma
- (2009) Caterina La Porta CURRENT CANCER DRUG TARGETS
- The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
- (2009) Li-Bing Song et al. JOURNAL OF CLINICAL INVESTIGATION
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
- miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases
- (2009) Derek M. Dykxhoorn et al. PLoS One
- lumi: a pipeline for processing Illumina microarray
- (2008) P. Du et al. BIOINFORMATICS
- Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma
- (2008) S J Liu et al. BRITISH JOURNAL OF CANCER
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours
- (2008) V. Häyry et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling
- (2008) Qing-Bai She et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started